The Plasma fractionation market share in 2026 is a crucial biopharmaceutical process used to separate plasma proteins from human blood plasma for therapeutic use. These proteins, including immunoglobulins, albumin, coagulation factors, and protease inhibitors, play a vital role in treating immune deficiencies, neurological disorders, and bleeding conditions. The rising awareness regarding plasma donation and advancements in fractionation technologies are further accelerating market growth globally.
According to Fortune Business Insights, the global plasma fractionation market size was valued at USD 40.27 billion in 2025 and is projected to grow from USD 43.55 billion in 2026 to USD 87.23 billion by 2034, exhibiting a CAGR of 9.1% during the forecast period. North America dominated the plasma fractionation market with a market share of 56.22% in 2025. The increasing prevalence of rare and chronic diseases, along with growing demand for plasma-derived therapies, is significantly contributing to market expansion.
The plasma fractionation market is primarily driven by the rising incidence of immunological and neurological disorders, which require plasma-derived therapies for effective treatment. Increasing use of immunoglobulins in treating primary immunodeficiency diseases and autoimmune conditions is boosting product demand. Additionally, the growing aging population and rising healthcare expenditure are further supporting market growth.
Technological advancements in plasma collection and fractionation processes have improved yield efficiency and product safety, encouraging pharmaceutical companies to expand their manufacturing capacities. Furthermore, increasing government initiatives and awareness programs related to plasma donation are positively influencing market development.
However, the market faces certain restraints, including stringent regulatory requirements for plasma collection and processing. High costs associated with plasma fractionation infrastructure and dependency on plasma donors may limit market growth. Additionally, supply chain challenges and limited availability of plasma in certain regions could hinder expansion.
The plasma fractionation market report provides a comprehensive analysis of key industry trends, growth drivers, restraints, and opportunities. It offers detailed insights into market size, share, and forecast, along with an in-depth evaluation of competitive dynamics. The report also highlights technological advancements, regulatory frameworks, and strategic initiatives undertaken by major players.